SETU hosts global experts to reshape cancer care in Ireland
With strong national and international partnerships, SETU is playing a pivotal role in shaping the future of cancer…
New biomarker predicts prognosis and treatment response in colorectal cancer
Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis…
Nanomedicine offers targeted solutions for breast cancer treatment
Breast cancer (BCA) is one of the most common cancers worldwide, with high mortality and morbidity in women.…
Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costing
Kazdal D, Endris V, Allgauer M, Kriegsmann M, Leichsenring J, Volckmar AL, et al. Spatial and temporal heterogeneity…
JMIR Publications’ new article showcases the transformative potential of precision oncology
JMIR Publications today announced the release of a timely new article in its News and Perspectives section, showcasing…
Metformin mimics exercise-related metabolic effects in prostate cancer patients
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise’s core…
Genomic study advances prioritization of variants in cancer diagnostics
Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number…
PSMA therapy may postpone hormone treatment in prostate cancer patients
Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have…
UMGCCC awarded $3 million to train the next generation of oncology researchers
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) has been awarded a prestigious $3 million National…
Study reveals how inflammation disrupts lymph node structure in lymphoma
In aggressive lymphomas, inflammatory messengers reprogram the “conductors” of the immune system, causing lymph nodes structure to collapse.…
TenBoron lands €7.6m EU grant for precision radiotherapy trials in hard-to-treat cancers
The funding will support Phase 1 and Phase 2 studies of the company’s lead candidate, TB0010, in patients…
Study links androgens to aggressive childhood brain tumor growth
An international team led by researchers at Baylor College of Medicine, Texas Children’s Hospital, McGill University and University…